“drug” or “drug product” include any substances of vegetable, animal or mineral origin or any preparation or admixture thereof manufactured, sold or advertised for use in: (a) the diagnosis, treatment, mitigation, in man or animal; (b) restoring, correcting or modifying organic function in man and animal; (c) disinfections or the control of vermin, insects or pest; or (d) contraception; “expiry date” means any date after which a drug is not recommended for use; “identification mark” means any single letter or combination of letters and numbers including e.g. words, company, mark, symbol, logo or monogram or a combination of letters, numbers and marks or symbols assigned by a drug firm to a specific drug product; “inactive ingredient” means any component other than an active ingredient; “ingredient” means any substance in the drug, whether added to the formulation as a single substance or in admixture with other substances; “inner label” means primary packaging material label; “label” includes any legend, word or mark attached to, included in, belonging to or accompanying any drug or package; “lot or batch number” means the number or a combination of numbers and letters specifically given to a drug which is linked to the manufacturing history of the drug; “outer label” means secondary packaging material label; “over- the-counter drug” means any drug other than a prescription drug; “package” includes any suitable container in which any drug is wholly or partly placed or packed; “package components” include primary packaging material, secondary packaging material or tertiary packaging material; “parenteral use” means administration of a drug by means of hypodermic syringes, needles or other instrument through or into the skin or mucous membrane; “prescription drug” means a drug which can only be made available to a patient through a written prescription signed by a duly qualified and registered medical or dental practitioner or veterinary surgeon and dispensed by a registered and licenced pharmacist 10